Cargando…

Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review

Detalles Bibliográficos
Autores principales:	Parker, Edward P K, Desai, Shalini, Marti, Melanie, Nohynek, Hanna, Kaslow, David C, Kochhar, Sonali, O'Brien, Katherine L, Hombach, Joachim, Wilder-Smith, Annelies
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846615/ https://www.ncbi.nlm.nih.gov/pubmed/35180408 http://dx.doi.org/10.1016/S2214-109X(21)00593-3

Ejemplares similares

Emerging evidence on heterologous COVID-19 vaccine schedules—To mix or not to mix?
por: Parker, Edward P K, et al.
Publicado: (2022)

Does the World Still Need New Covid-19 Vaccines?
por: Nohynek, Hanna, et al.
Publicado: (2022)

Safety and reactogenicity of second booster doses for mRNA vaccines
por: Wilder-Smith, Annelies, et al.
Publicado: (2023)

Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection
por: Sun, Fangfang, et al.
Publicado: (2022)

Announcing the Publication of a WHO Guide to the Design and Interpretation of Observational Influenza Vaccine Effectiveness Studies
por: Ortiz, Justin R., et al.
Publicado: (2017)

Challenges in Antimicrobial Stewardship: Rapid Diagnostics and Optimization of Therapy Among Immunocompromised Patients
por: Rosa, Rossana, et al.
Publicado: (2019)

The global community needs to swiftly ramp up the response to contain COVID-19
por: Fisher, Dale, et al.
Publicado: (2020)

Rat Hepatitis E in an Immunocompromised Patient
por: Hon, Kam Lun, et al.
Publicado: (2020)

Isoscartopic Response: Another Facet of the Immunocompromised Cutaneous District
por: Caccavale, Stefano, et al.
Publicado: (2016)

An Opportunity to Better Understand the Impact of Coronaviruses on Immunocompromised Patients
por: Parisi, Christina
Publicado: (2020)

Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19
por: Destras, Grégory, et al.
Publicado: (2021)

The unmet need for COVID-19 treatment in immunocompromised patients
por: Alessandra, D’Abramo, et al.
Publicado: (2022)

Institutional versus home isolation to curb the COVID-19 outbreak – Authors' reply
por: Wilder-Smith, Annelies, et al.
Publicado: (2020)

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
por: Choi, Bina, et al.
Publicado: (2020)

Radiation Port Cutaneous Metastases: A Further Example of Immunocompromised District
por: Ruocco, Eleonora, et al.
Publicado: (2014)

Potential benefit of convalescent plasma transfusions in immunocompromised patients with COVID-19
por: Rodionov, Roman N, et al.
Publicado: (2021)

SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients
por: Scherer, Erin M., et al.
Publicado: (2022)

Molnupiravir efficacy among immunocompromised patients with COVID-19: no proof of concept
por: Guermazi, Dorra, et al.
Publicado: (2023)

Dermoscopy of Partially Pigmented Bowen's Disease in an Immunocompromised Patient: An Emphasis on White Rosettes
por: Ankad, Balachandra S., et al.
Publicado: (2023)

Estimating the proportion of vaccine-induced hospitalized dengue cases among Dengvaxia vaccinees in the Philippines
por: Flasche, Stefan, et al.
Publicado: (2019)

SARS-CoV-2 population-based seroprevalence studies in Europe: a scoping review
por: Grant, Rebecca, et al.
Publicado: (2021)

The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines
por: Sanvictores, Diozele Hazel M, et al.
Publicado: (2012)

Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection
por: Reuken, Philipp A., et al.
Publicado: (2021)

Staying Awake in Severe Acute Respiratory Distress Syndrome: A Perspective on Immunocompromised Patients
por: Stahl, Klaus, et al.
Publicado: (2021)

Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients
por: Destras, Grégory, et al.
Publicado: (2022)

Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients
por: Solera, Javier T, et al.
Publicado: (2023)

Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection
por: Staples, J. Erin, et al.
Publicado: (2020)

Geographic Information System and tools of spatial analysis in a pneumococcal vaccine trial
por: Tanskanen, Antti, et al.
Publicado: (2012)

Immunocompromise and durability of BNT162b2 vaccine against severe outcomes due to omicron and delta variants
por: Tartof, Sara Y, et al.
Publicado: (2022)

COVID-19 screening of health-care workers in a London maternity hospital
por: Khalil, Asma, et al.
Publicado: (2021)

Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates
por: Vannice, Kirsten S., et al.
Publicado: (2019)

Authors’ response
por: Bhadada, S. K., et al.
Publicado: (2018)

Additional perspectives on chronic kidney disease of unknown aetiology (CKDu) in Sri Lanka – lessons learned from the WHO CKDu population prevalence study
por: Redmon, Jennifer Hoponick, et al.
Publicado: (2014)

Transparent Development of WHO Rapid Advice Guidelines: A Useful Approach
por: Cunha, Antonio
Publicado: (2007)

Reply: Antibiotic prophylaxis in palliative patients with cirrhosis: Stewardship or gatekeeping?
por: O'Brien, Alastair, et al.
Publicado: (2023)

Vaccines and therapeutics for immunocompromised patients with COVID-19
por: Shoham, Shmuel, et al.
Publicado: (2023)

Testing for Cytomegalovirus Among Individuals Who Were Immunocompromised, 2018-2022
por: Jain, Purva, et al.
Publicado: (2023)

Reduced left atrial strain can predict stroke in atrial fibrillation – A meta-analysis
por: Sachdeva, Sonali, et al.
Publicado: (2021)

Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance
por: Hills, Susan, et al.
Publicado: (2009)

The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making
por: Hutubessy, Raymond, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9698h9v3eihr8d8ggg7tdii0fv